Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire

ConclusionsThe Polish version of the OABSS is a reliable tool for females suffering from UI. However, OABSS does not distinguish patients with MUI from patients with OAB.
Source: International Urogynecology Journal - Category: OBGYN Source Type: research

Related Links:

CONCLUSION: LACS allowed the anatomical reconstruction of the pelvic floor and proved to be a minimally invasive, fast, effective, safe and reproducible technique. More series are needed to evaluate its role against laparoscopic colposacropexy. PMID: 33032847 [PubMed - as supplied by publisher]
Source: Actas Urologicas Espanolas - Category: Urology & Nephrology Authors: Tags: Actas Urol Esp Source Type: research
Conclusions Three-dimensional ultrasound urodynamics can be used to identify differences in bladder shape comparing individuals with and without OAB. This method may be used to identify a subset of OAB patients with abnormal bladder shapes which may play a role in the pathophysiology of their OAB symptoms.
Source: Female Pelvic Medicine and Reconstructive Surgery - Category: OBGYN Tags: Original Articles Source Type: research
Conclusions Choline levels are significantly decreased in women complaining of OAB with urgency incontinence, and lower levels are associated with higher MESA scores.
Source: Female Pelvic Medicine and Reconstructive Surgery - Category: OBGYN Tags: Original Articles Source Type: research
Conditions:   Urge Incontinence;   Overactive Bladder (OAB) Intervention:   Drug: mirabegron Sponsor:   Astellas Pharma China, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Urge Incontinence;   Overactive Bladder (OAB) Intervention:   Drug: mirabegron Sponsor:   Astellas Pharma China, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Urge Incontinence;   Overactive Bladder (OAB) Intervention:   Drug: mirabegron Sponsor:   Astellas Pharma China, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Urge Incontinence;   Overactive Bladder (OAB) Intervention:   Drug: mirabegron Sponsor:   Astellas Pharma China, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Urge Incontinence;   Overactive Bladder (OAB) Intervention:   Drug: mirabegron Sponsor:   Astellas Pharma China, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Urge Incontinence;   Overactive Bladder (OAB) Intervention:   Drug: mirabegron Sponsor:   Astellas Pharma China, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Urge Incontinence;   Overactive Bladder (OAB) Intervention:   Drug: mirabegron Sponsor:   Astellas Pharma China, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Incontinence | OBGYN | Overactive Bladder | Overactive Bladder Syndrome | Poland Health | Statistics | Study | Women